• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment.

作者信息

Yanagihara T, Tanaka K, Ota K, Kashiwagi E, Takeuchi A, Tatsugami K, Eto M, Nakanishi Y, Okamoto I

机构信息

Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Ann Oncol. 2017 Aug 1;28(8):2038-2039. doi: 10.1093/annonc/mdx214.

DOI:10.1093/annonc/mdx214
PMID:28459940
Abstract
摘要

相似文献

1
Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment.在纳武单抗治疗期间，肿瘤浸润淋巴细胞介导的胸膜炎，随后胸壁转移性肾癌显著缩小。
Ann Oncol. 2017 Aug 1;28(8):2038-2039. doi: 10.1093/annonc/mdx214.
2
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma.CheckMate 025 随机 3 期研究：纳武利尤单抗对比依维莫司治疗晚期肾细胞癌的关键基线因素和既往治疗的结局。
Eur Urol. 2017 Dec;72(6):962-971. doi: 10.1016/j.eururo.2017.02.010. Epub 2017 Mar 3.
3
Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab.对纳武单抗有显著反应的未分类肾细胞癌。
Clin Genitourin Cancer. 2017 Jun;15(3):e517-e519. doi: 10.1016/j.clgc.2016.12.019. Epub 2016 Dec 29.
4
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.纳武利尤单抗治疗转移性肾细胞癌患者的疾病进展模式、预测因素和后续结局。
J Immunother Cancer. 2018 Oct 17;6(1):107. doi: 10.1186/s40425-018-0425-8.
5
An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma.纳武利尤单抗治疗转移性肾细胞癌的评价。
Expert Opin Biol Ther. 2018 Jun;18(6):695-705. doi: 10.1080/14712598.2018.1478962. Epub 2018 Jun 4.
6
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab.纳武单抗治疗的晚期肾癌患者肿瘤浸润与循环淋巴细胞亚群之间的相关性
Acta Biomed. 2019 Dec 23;90(4):468-474. doi: 10.23750/abm.v90i4.7057.
7
Newly developing brain metastases during nivolumab therapy for metastatic renal cell carcinoma: A case series in two Japanese institutions.纳武单抗治疗转移性肾细胞癌期间新发脑转移瘤：日本两家机构的病例系列报道
Int J Urol. 2019 Aug;26(8):849-850. doi: 10.1111/iju.14020. Epub 2019 May 21.
8
Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile.纳武单抗再激发治疗转移性肾细胞癌的卓越反应及基因组图谱的平行变化
Eur Urol. 2018 Feb;73(2):308-310. doi: 10.1016/j.eururo.2017.08.006. Epub 2017 Aug 24.
9
What advances have been made in immune-therapy for renal cell carcinoma?肾细胞癌免疫治疗取得了哪些进展？
Future Oncol. 2017 Apr;13(8):665-668. doi: 10.2217/fon-2017-0026. Epub 2017 Feb 10.
10
Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy.纳武利尤单抗治疗肾细胞癌的聚焦：设计、研发及治疗地位
Drug Des Devel Ther. 2017 Apr 11;11:1175-1182. doi: 10.2147/DDDT.S110209. eCollection 2017.

引用本文的文献

1
Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis.探索性质谱细胞术分析揭示了癌症治疗相关肺炎的免疫表型。
Elife. 2024 Apr 12;12:RP87288. doi: 10.7554/eLife.87288.
2
Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report.帕博利珠单抗治疗卵巢癌患者期间发生心脏压塞：一例病例报告
Int Cancer Conf J. 2023 Jul 5;12(4):305-310. doi: 10.1007/s13691-023-00621-x. eCollection 2023 Oct.
3
Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis.
免疫检查点抑制剂相关肺炎的潜在发病机制及治疗选择的见解
Biomedicines. 2021 Oct 16;9(10):1484. doi: 10.3390/biomedicines9101484.
4
Chronic Pleuritis and Recurrent Pleural Effusion After Atezolizumab for Small Cell Lung Cancer.阿特珠单抗治疗小细胞肺癌后出现慢性胸膜炎和复发性胸腔积液。
Am J Case Rep. 2021 Oct 4;22:e933396. doi: 10.12659/AJCR.933396.
5
Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report.进展性胸腔积液作为非小细胞肺癌的免疫相关不良事件：一例报告
JTO Clin Res Rep. 2021 Feb 17;2(5):100156. doi: 10.1016/j.jtocrr.2021.100156. eCollection 2021 May.
6
Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer.纳武利尤单抗治疗晚期胃癌后并发乳糜性腹水行转换手术成功。
In Vivo. 2020 Mar-Apr;34(2):583-585. doi: 10.21873/invivo.11810.
7
Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer.免疫检查点抑制剂在非小细胞肺癌患者中的肺部并发症。
Eur Respir Rev. 2019 Oct 9;28(153). doi: 10.1183/16000617.0058-2019. Print 2019 Sep 30.
8
Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade.免疫检查点阻断治疗期间癌症患者瘤周胸腔积液和肺炎病变中相同T细胞克隆的检测
Oncotarget. 2018 Jul 17;9(55):30587-30593. doi: 10.18632/oncotarget.25743.